FMT holds potential for treating various diseases beyond C. difficile infection, but its regulation by the FDA is crucial due to concerns about long-term effects and unintentional disease transfer.
Keep Reading
Add A Comment
Trending
- Pfizer’s $10B monthly GLP-1 bet generates competitive weight loss in phase 2b (Fierce Biotech)
- ‘AI-native’ outpatient surgery startup Oath Surgical inks Nvidia partnership (Fierce Biotech)
- NVIDIA, Oath Surgical, ASCs and the Future of Physical AI in Healthcare (LSI | LinkedIn)
- UMass Successfully Performs Its First Full-Thickness Resection Device Procedure (UMass Chan Medical School)
- 5 gastroenterology physician moves in 1 month (Becker’s GI & Endoscopy)
- Artificial Intelligence on Trial: Who’s Liable When Clinical Algorithms Go Wrong? (Medscape)
- Building the Future Gastroenterologist: Why Nutrition and Lifestyle Medicine Must Be Core Competencies (ACG Case Reports Journal)
- Spray Cryotherapy Esophageal Consortium Consensus Recommendations for Liquid Nitrogen Spray Cryotherapy in Barrett’s Esophagus and Esophageal Cancer Using a Modified Delphi Process (The American Journal of Gastroenterology)
